Table 5.
Indications and outcomes of lumen apposing metal stent placement
Type of study | Number of patients | Indication for LAMS | Technical success (%) | Clinical success (%) | Adverse events (%) | Reference |
---|---|---|---|---|---|---|
Meta-analysis | 737 | Pancreatic walled off necrosis | - | 88.5% (95% CI 82.5-92.6 | 11.2% (95% CI 6.8-17.9) | Mohan et al. |
Meta-analysis | 332 | Pancreatic pseudocysts | 95.76% | 94.06% | - | Lyu et al. |
Meta-analysis | 1437 | Biliary drainage | 91.5% (95% CI 87.7-94.2) | 87% (95% CI 82.3-90.6) | 17.9% (95% CI 14.3-22.2) | Dhindsa et al. |
Meta-analysis | 278 | Palliation of gastric outlet obstruction | 95.2% (CI 87.2-98.3) | 93.3% (CI 84.4-97.3) | 10.7% (CI 4.3-24.5) | Chandan et al. |
Meta-analysis | 1538 | Symptomatic gallbladder disease | 94.65% (95% CI 91.54-96.67) | 92.06% (95% CI 88.65-94.51) | 11.71% (95% CI 8.92-15.23) | McCarty et al. |
Retrospective | 46 | Malignant distal biliary obstruction | 93.5% | 97.7% | 11.6% | Anderloni et al. |
Multicenter retrospective | 47 | Postsurgical fluid collections | 93.6% | 89.3% | 4.25% | Mudireddy et al. |
CI: Confidence interval; LAMS: Lumen-apposing stent